Search

everythinglearnresearchcommunity

for

Search:↓

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Hydroxytyrosol helps reduce liver injury by blocking certain inflammation pathways.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Interferon therapy is a promising and safe treatment for hepatitis B in Southeast Asia.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Cyclosporin A vesicles effectively regrow hair and reduce inflammation in alopecia areata.

Cytokines play a key role in hair loss, and certain treatments may help manage androgenic alopecia.

JAK inhibitors show promise for treating various skin diseases.

Nonimmunosuppressive cyclosporines might treat skin diseases by affecting cell growth.

Antiandrogens don't help with COVID-19 and aren't recommended.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.